Close

Pre-Open Stock Movers 10/19: (WATT) (ETTX) (HRMY) Higher; (AVIR) (GRTX) (MGNI) Lower (more...)

October 19, 2021 9:22 AM EDT

Pre-Open Stock Movers:

Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) 72.6% LOWER; reported that the global Phase 2 MOONSONG trial evaluating AT-527 in the outpatient setting did not meet the primary endpoint of reduction from baseline in the amount of SARS-CoV-2 virus in patients with mild or moderate COVID-19 compared to placebo in the overall study population, of which approximately two thirds of patients were low-risk with mild symptoms. However, in high-risk patients with underlying health conditions, a reduction of viral load of approximately 0.5 log10 at Day 7 was observed at 550 mg (prespecified subgroup analysis) and 1,100 mg BID (exploratory subgroup analysis) compared with placebo.

Galera Therapeutics, Inc. (Nasdaq: GRTX) 71.6% LOWER; announced results from the Phase 3 ROMAN trial of avasopasem manganese (avasopasem) for severe oral mucositis (SOM) in patients with locally advanced head and neck cancer (HNC) undergoing standard-of-care radiotherapy. The trial did not meet its primary endpoint of reduction in the incidence of SOM. The Company is continuing to analyze the results.

Energous Corporation (Nasdaq: WATT) 28.5% HIGHER; announced that its 900MHz 1W Active Energy Harvesting transmitter technology has received U.S. Federal Communications Commission (FCC) Part 15 grant of equipment authorization for wireless power transfer at any distance. This approval complements a similar unlimited distance wireless charging approval in Europe, announced in May, 2021, expanding the ecosystem reach -- including customers, OEM partners and standards organizations -- for WattUp. The 1W Active Energy Harvesting transmitter can charge multiple devices at once, enabling at-any-distance over-the-air charging for the growing ecosystem of Internet of Things devices such as retail sensors, electronic shelf labels, industrial devices and more.

Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX) 22.2% HIGHER; announced topline results from its ATTACK triala global Phase 3 registrational trial evaluating the safety and efficacy of SUL-DUR versus colistin in patients with infections caused by Acinetobacter baumannii. SUL-DUR met the primary endpoint of 28-day all-cause mortality in patients with carbapenem-resistant Acinetobacter infections (CRABC m-MITT* population in Part A of the study), demonstrating statistical non-inferiority versus colistin. Mortality analyses favored SUL-DUR versus colistin in CRABC m-MITT and all study populations included in the topline results. At Test of Cure, there was a statistically significant difference in clinical response favoring SUL-DUR over colistin. SUL-DUR met the primary safety objective of the study achieving statistically significant reduction in nephrotoxicity.

Harmony Biosciences Holdings Inc. (NASDAQ: HRMY) 12.5% HIGHER; will replace Retail Properties of America Inc. (NYSE: RPAI) in the S&P SmallCap 600

TaskUs, Inc. (NASDAQ: TASK) 6.8% LOWER; announced today that certain of its stockholders have commenced an underwritten public offering of 10,000,000 shares of TaskUs Class A common stock. In connection with the offering, the selling stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of Class A common stock.

Dermata Therapeutics, Inc. (NASDAQ: DRMA) 6% HIGHER; announced positive topline results from its Phase 1b trial of DMT310 in 30 patients as a once-weekly topical application for the treatment of mild-to-moderate psoriasis. DMT310 is Dermata's lead product candidate, with both mechanical and chemical mechanisms of action, currently being investigated to treat multiple inflammatory skin conditions, including acne, psoriasis, and rosacea.

EverQuote, Inc. (Nasdaq: EVER) 5.5% LOWER; Total revenue is expected to be in the range of $106.5 $107.5 million, compared to guidance of $109 - $111 million.

Coinbase (NASDAQ: COIN) 3.3% HIGHER; Facebook (NASDAQ: FB) has chosen Coinbase (NASDAQ: COIN) as its custody partner for its pilot of Novi, a new digital wallet that enables people to send and receive money abroad instantly, securely, and with no fees.

Kite Realty Group Trust (NYSE: KRG) 3% LOWER; will replace LendingTree Inc. (NASDAQ: TREE) in the S&P MidCap 400

Steel Dynamics (NASDAQ: STLD) 1.5% HIGHER; Q3 results, with EPS coming in at $4.96, beating the consensus estimate of $4.57. Quarterly revenue was a record $5.1 billion (vs. $2.3 billion in Q3/20), better than the consensus estimate of $4.98 billion.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Standard & Poor's, Pre-Open Losers, Pre-Open Winners, Pre Market Movers